Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea

被引:30
作者
Song, Margaret
Seo, Sang-Hee [3 ]
Ko, Hyun-Chang [2 ]
Oh, Chang-Keun
Kwon, Kyung-Sool [2 ]
Chang, Chulhun L. [4 ]
Kim, Moon-Bum [1 ,2 ]
机构
[1] Pusan Natl Univ, Sch Med, Dept Dermatol, Pusan 602739, South Korea
[2] Pusan Natl Univ, Med Res Inst, Pusan 602739, South Korea
[3] Yangsan Pusan Natl Univ, Sch Med, Dept Dermatol, Pusan, South Korea
[4] Yangsan Pusan Natl Univ, Sch Med, Dept Lab Med, Pusan, South Korea
关键词
acne vulgaris; antibiotic susceptibility; antibiotics; minimal inhibitory concentration; Propionibacterium acnes; RESISTANT PROPIONIBACTERIA; PREVALENCE; THERAPY; EUROPE; SKIN;
D O I
10.1111/j.1346-8138.2010.01109.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Propionibacterium acnes plays an important role in the development of acne, and inflammatory lesions are improved by antibiotics. Long-term use of antibiotics may result in development of resistant strains and treatment failure. The aim of the present study was to investigate the isolation rate of P. acnes and to evaluate its antibiotic susceptibility to widely used antibiotics in acne in Korea. Among 46 patients, 31 P. acnes strains were cultured. Isolated P. acnes was measured for minimum inhibitory concentration (MIC) of tetracycline, doxycycline, minocycline, erythromycin and clindamycin using an Epsilometer test. Age, disease duration and previous history of antibiotic therapy for acne were compared in relation to the MIC. The mean MIC of tetracycline, minocyclines, doxycycline, clindamycin and erythromycin were all below the breakpoint of antibiotic resistance. The patients with acne vulgaris with disease duration of more than 2 years documented higher MIC values in doxycycline, erythromycin, and clindamycin than those of less than 2 years. The patients who were previously treated with topical or systemic antibiotics showed higher MIC in doxycycline. Antibiotic resistance of P. acnes is still low in Korea, but at this point, there is an increasing trend of MIC. Caution and acknowledgement of increased risk of antibiotic resistant P. acnes should be advised in acne antibiotic treatment to minimize and avoid the emergence of the resistant strain.
引用
收藏
页码:667 / 673
页数:7
相关论文
共 23 条
[1]   Prevalence of antibiotic-resistant propionibacteria on the skin of acne patients: 10-year surveillance data and snapshot distribution study [J].
Coates, P ;
Vyakrnam, S ;
Eady, EA ;
Jones, CE ;
Cove, JH ;
Cunliffe, WJ .
BRITISH JOURNAL OF DERMATOLOGY, 2002, 146 (05) :840-848
[2]   Is antibiotic resistance in cutaneous propionibacteria clinically relevant? Implications of resistance for acne, patients and prescribers [J].
Eady, AE ;
Cove, JH ;
Layton, AM .
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2003, 4 (12) :813-831
[3]   ERYTHROMYCIN RESISTANT PROPIONIBACTERIA IN ANTIBIOTIC TREATED ACNE PATIENTS - ASSOCIATION WITH THERAPEUTIC FAILURE [J].
EADY, EA ;
COVE, JH ;
HOLLAND, KT ;
CUNLIFFE, WJ .
BRITISH JOURNAL OF DERMATOLOGY, 1989, 121 (01) :51-57
[4]   Propionibacterium acnes resistance:: A worldwide problem [J].
Eady, EA ;
Gloor, M ;
Leyden, JJ .
DERMATOLOGY, 2003, 206 (01) :54-56
[5]   Comparative in vitro activities of retapamulin (SB-275833) against 141 clinical isolates of Propionibacterium spp., including 117 P-acnes isolates [J].
Goldstein, EJC ;
Citron, DM ;
Merriam, CV ;
Warren, YA ;
Tyrrell, KL ;
Fernandez, HT .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (01) :379-381
[6]   Management of acne - A report from a global alliance to improve outcomes in acne [J].
Gollnick, H ;
Cunliffe, W ;
Berson, D ;
Dreno, B ;
Finlay, A ;
Leyden, JJ ;
Shalita, AR ;
Thiboutot, D .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2003, 49 (01) :S1-S37
[7]  
Goulden V, 1999, J AM ACAD DERMATOL, V41, P577, DOI 10.1016/S0190-9622(99)80056-5
[8]   Antimicrobial susceptibilities of Propionibacterium acnes isolated from patients with acne vulgaris [J].
Ishida, Natsumi ;
Nakaminami, Hidemasa ;
Noguchi, Norihisa ;
Kurokawa, Ichiro ;
Nishijima, Setsuko ;
Sasatsu, Masanori .
MICROBIOLOGY AND IMMUNOLOGY, 2008, 52 (12) :621-624
[9]  
Ki H.G., 2005, KOREAN J DERMATOL, V43, P871
[10]  
Kurokawa I, 1999, EUR J DERMATOL, V9, P25